Acute Coronary SyndromeNCT02306616

CCC Project- Acute Coronary Syndrome

An observational study of Acute Coronary Syndrome, run by Beijing Institute of Heart, Lung and Blood Vessel Diseases at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

Who is it for?: Any age
Conditions the study is for: Acute Coronary Syndrome
How many people: 124,363 participants
Where: 1 siteChina
Study dates: Nov 2014to Dec 2020
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages Any age
All sexes
No healthy volunteers
Child, Adult, Older adult

Study population: Hospitalized patients with acute coronary syndrome

Who may be able to join

Hospitalized patients with discharge diagnosis as acute coronary syndrome (including STEMI, NSTEMI and UAP) in 150 tertiary and 100 secondary hospitals.

Who cannot join

None

Trial locations and contacts

1 site in 1 country.

China1 site

Beijing An Zhen Hospital
Beijing

Other trials in China

About this study

Official title: Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome

To develop and implement quality improvement programs for the treatment of acute coronary syndrome (ACS) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of acute coronary syndrome.

Conditions: Acute Coronary Syndrome
Medical subject headings: Acute Coronary Syndrome

What is being measured

The primary outcome is the main question the study is designed to answer.

The overall composite of 11 performance measures for ACS care
Performance measures for ACS care including:
1. Proportion of patients received aspirin at arrival
2. Proportion of patients received fibrinolytic therapy within 30 mins (STEMI)
3. Proportion of patients received primary percutaneous coronary intervention within 90 mins (STEMI)
4. Proportion of patients received reperfusion therapy (STEMI)
5. Proportion of patients with aspirin prescribed at discharge
6. Proportion of patients with clopidogrel or other P2Y12 inhibitors prescribed at discharge
7. Proportion of patients with beta-blocker prescribed at discharge
8. Proportion of patients with statin prescribed at discharge
9. Proportion of patients received evaluation of left ventricular systolic function
10. Proportion of left ventricular systolic dysfunction patients with ACEI or ARB prescribed at discharge
11. Proportion of patients received smoking cessation advice/ counseling
Measured: Duration of hospital stay, an expected average of 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

Nov 2014Dec 2020

First posted3 Dec 2014 (estimated)
Study startNov 2014
Primary completionDec 2020
Study completionDec 2020

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Publications (39)Papers the sponsor has linked to this study.
Other trials for Acute Coronary SyndromeStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Observational model: Case only
Time perspective: Retrospective
Enrolment: 124,363 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT02306616
Sponsor's protocol ID: CCC-ACS-2014
Status last verified: Jan 2021
First submitted: 29 Nov 2014
Last updated: 27 Jan 2021
Results posted: No

Publications

Hao Y, Liu J, Liu J, Smith SC Jr, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Zhang Q, Wang W, Zhao D; CCC-ACS Investigators. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. Am Heart J. 2016 Sep;179:107-15. doi: 10.1016/j.ahj.2016.06.005. Epub 2016 Jun 18.
PubMed 27595685
Yang Q, Wang Y, Liu J, Liu J, Hao Y, Smith SC Jr, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Wang W, Zhou Y, Zhao D; CCC-ACS Investigators. Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China). Circ Cardiovasc Interv. 2017 Jun;10(6):e004750. doi: 10.1161/CIRCINTERVENTIONS.116.004750.
PubMed 28606999
Zhao G, Zhou M, Ma C, Huo Y, Smith SC Jr, Fonarow GC, Ge J, Han Y, Liu J, Hao Y, Liu J, Wang X, Taubert KA, Morgan L, Zhao D, Nie S; CCC-ACS Investigators. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project. J Am Heart Assoc. 2018 Mar 30;7(7):e008100. doi: 10.1161/JAHA.117.008100.
PubMed 29602767
Zhou M, Liu J, Hao Y, Liu J, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Yang N, Xing Y, Zhao D; CCC-ACS Investigators. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovasc Diabetol. 2018 Nov 27;17(1):147. doi: 10.1186/s12933-018-0793-x.
PubMed 30482187
Xing Y, Liu J, Hao Y, Liu J, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Yang N, Zhou M, Zhao D; CCC-ACS Investigators. Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project. Am Heart J. 2019 Jun;212:120-128. doi: 10.1016/j.ahj.2019.02.019. Epub 2019 Mar 13.
PubMed 30986750
Yang N, Liu J, Liu J, Hao Y, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Zhou M, Xing Y, Zhao D; CCC-ACS Investigators. Performance on management strategies with Class I Recommendation and A Level of Evidence among hospitalized patients with non-ST-segment elevation acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project. Am Heart J. 2019 Jun;212:80-90. doi: 10.1016/j.ahj.2019.02.012. Epub 2019 Mar 4.
PubMed 30981036
Hao Y, Liu J, Liu J, Yang N, Smith SC Jr, Huo Y, Fonarow GC, Ge J, Taubert KA, Morgan L, Zhou M, Xing Y, Ma CS, Han Y, Zhao D. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome. Circulation. 2019 Apr 9;139(15):1776-1785. doi: 10.1161/CIRCULATIONAHA.118.037655.
PubMed 30667281
Wang C, Xu Z, Hao YC. Factors associated with length of stay among patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the CCC-ACS project. Open Heart. 2026 Jul 31;13(2):e004238. doi: 10.1136/openhrt-2026-004238.
PubMed 42538061
Zhang M, Zhao Z, Liu Y, Ma H, Wang K, Liu T, Yang W, Zhao Y, Luo W, Zhao X, Zheng K, Yin C, Zhang X, Gao H, Zhou C, Zhao D. Transradial Access vs. Transfemoral Access for Primary PCI in ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: Findings from a National, Multicenter Registry and Meta-Analysis. Korean Circ J. 2026 Aug;56(8):694-709. doi: 10.4070/kcj.2025.0251. Epub 2026 Mar 11.
PubMed 41972267
Liu Y, Liu X, Sun D, Gu R, Li M, Wang X. Aspirin Combined With Ticagrelor or Clopidogrel in STEMI Patients With Diabetes Mellitus and Poor Glycemic Control Undergoing Primary PCI: A Multicenter Retrospective Cohort Study. Catheter Cardiovasc Interv. 2026 Apr;107(5):1562-1572. doi: 10.1002/ccd.70503. Epub 2026 Feb 8.
PubMed 41656976
Fan C, Yan H, Lei K, Li D, Dong S, Zhang Y, Callister CP, Cheng Y, Li Z, Li Z, Qian H, Huang J. In-hospital outcomes of percutaneous coronary intervention in acute coronary syndrome patients with heart failure: a real-world observational study from the CCC-ACS registry. BMC Cardiovasc Disord. 2025 Dec 30;26(1):62. doi: 10.1186/s12872-025-05389-x.
PubMed 41469572
Zhou Z, Xie H, Fan F, Yang F, Jiang J, Zheng B, Zhang Y, Hao Y, Liu J, Gong Y, Zhao D, Smith SC, Huo Y. Comparison of in-hospital net clinical outcomes of ticagrelor and clopidogrel in acute coronary syndrome patients stratified by CRUSADE score: findings from the CCC-ACS registry. Platelets. 2025 Dec;36(1):2570743. doi: 10.1080/09537104.2025.2570743. Epub 2025 Oct 27.
PubMed 41143351
Zhou C, Zhang M, Zhao Z, Li E, Zhao Y, Luo W, Zheng K, Liu Y, Yin C, Zhang X, Gao H, Zhao D, Ma C. Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI : Findings from a National, multicenter registry. Thromb J. 2025 Apr 22;23(1):38. doi: 10.1186/s12959-025-00721-z.
PubMed 40264117
Zhou C, Zhang M, Zhao Z, Li E, Zhao Y, Wang H, Luo W, Zheng K, Liu Y, Yin C, Zhang X, Gao H, Hou X, Zhao D, Ma C. Safety and efficacy of post-procedure anticoagulation in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary percutaneous coronary intervention. BMC Cardiovasc Disord. 2025 Mar 28;25(1):231. doi: 10.1186/s12872-025-04639-2.
PubMed 40155819
Zhang Y, Hao Y, Liu J, Yang N, Smith SC Jr, Huo Y, Fonarow GC, Ge J, Morgan L, Sun Z, Hu D, Yang Y, Ma CS, Zhao D, Han Y, Liu J, Zeng Y; CCC-ACS Investigators. Percutaneous coronary intervention in patients with acute coronary syndromes and increased platelet count. Arch Cardiovasc Dis. 2025 May;118(5):304-311. doi: 10.1016/j.acvd.2025.01.005. Epub 2025 Feb 13.
PubMed 39984408

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

RecruitingPhase 4
CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome
ACS (Acute Coronary Syndrome), SGLT2 Inhibitors
Recruiting
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
Coronary Arterial Disease (CAD), Plaque
Not yet recruitingPhase 4
Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia
Acute Coronary Syndrome
Enrolling by invitation
Optical Coherence Tomography in Acute Vessel Evaluation
Ischemic Heart Disease, Ischemic Coronary Artery Disease
Not yet recruitingPhase 3
Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis
Giant Cell Arteritis (GCA), Acute Coronary Syndrome (ACS)

All Acute Coronary Syndrome trials

Study at a glance

From the registry record, last updated by the sponsor on 27 Jan 2021. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome
ClinicalTrials.gov ID: NCT02306616
Acronym / sponsor ID: CCC-ACS-2014
Conditions: Acute Coronary Syndrome
Study type: Observational
Recruitment status: Completed
Enrolment: 124,363 participants (actual)
Lead sponsor: Beijing Institute of Heart, Lung and Blood Vessel DiseasesUniversity, hospital or other
Collaborators: American Heart Association, Chinese Society of Cardiology
Study start: Nov 2014
Primary completion: Dec 2020 (actual)
Study completion: Dec 2020 (actual)
First posted: 3 Dec 2014 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Observational model: Case only
Time perspective: Retrospective

Who may qualify

Sex: All
Healthy volunteers: Not accepted
Age groups: Child, Adult, Older adult
Study population: Hospitalized patients with acute coronary syndrome

Key inclusion criteria (1 listed)

Hospitalized patients with discharge diagnosis as acute coronary syndrome (including STEMI, NSTEMI and UAP) in 150 tertiary and 100 secondary hospitals.

Key exclusion criteria (1 listed)

None

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

The overall composite of 11 performance measures for ACS care
Time frame: Duration of hospital stay, an expected average of 1 week
Performance measures for ACS care including: 1. Proportion of patients received aspirin at arrival 2. Proportion of patients received fibrinolytic therapy within 30 mins (STEMI) 3. Proportion of patients received primary percutaneous coronary intervention within 90 mins (STEMI) 4. Proportion of patients received reperfusion therapy (STEMI) 5. Proportion of patients with aspirin prescribed at discharge 6. Proportion of patients with clopidogrel or other P2Y12 inhibitors prescribed at discharge 7. Proportion of patients with beta-blocker prescribed at discharge 8. Proportion of patients with statin prescribed at discharge 9. Proportion of patients received evaluation of left ventricular systolic function 10. Proportion of left ventricular systolic dysfunction patients with ACEI or ARB prescribed at discharge 11. Proportion of patients received smoking cessation advice/ counseling

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 27 Jan 2021.
Results publication: PubMed 27595685Hao Y, Liu J, Liu J, Smith SC Jr, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Zhang Q, Wang W, Zhao D; CCC-ACS Investigators. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. Am Heart J. 2016 Sep;179:107-15. doi: 10.1016/j.ahj.2016.06.005. Epub 2016 Jun 18.
Results publication: PubMed 28606999Yang Q, Wang Y, Liu J, Liu J, Hao Y, Smith SC Jr, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Wang W, Zhou Y, Zhao D; CCC-ACS Investigators. Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China). Circ Cardiovasc Interv. 2017 Jun;10(6):e004750. doi: 10.1161/CIRCINTERVENTIONS.116.004750.
Results publication: PubMed 29602767Zhao G, Zhou M, Ma C, Huo Y, Smith SC Jr, Fonarow GC, Ge J, Han Y, Liu J, Hao Y, Liu J, Wang X, Taubert KA, Morgan L, Zhao D, Nie S; CCC-ACS Investigators. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project. J Am Heart Assoc. 2018 Mar 30;7(7):e008100. doi: 10.1161/JAHA.117.008100.
Results publication: PubMed 30482187Zhou M, Liu J, Hao Y, Liu J, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Yang N, Xing Y, Zhao D; CCC-ACS Investigators. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovasc Diabetol. 2018 Nov 27;17(1):147. doi: 10.1186/s12933-018-0793-x.
Results publication: PubMed 30986750Xing Y, Liu J, Hao Y, Liu J, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Yang N, Zhou M, Zhao D; CCC-ACS Investigators. Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project. Am Heart J. 2019 Jun;212:120-128. doi: 10.1016/j.ahj.2019.02.019. Epub 2019 Mar 13.
Results publication: PubMed 30981036Yang N, Liu J, Liu J, Hao Y, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Zhou M, Xing Y, Zhao D; CCC-ACS Investigators. Performance on management strategies with Class I Recommendation and A Level of Evidence among hospitalized patients with non-ST-segment elevation acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project. Am Heart J. 2019 Jun;212:80-90. doi: 10.1016/j.ahj.2019.02.012. Epub 2019 Mar 4.
Results publication: PubMed 30667281Hao Y, Liu J, Liu J, Yang N, Smith SC Jr, Huo Y, Fonarow GC, Ge J, Taubert KA, Morgan L, Zhou M, Xing Y, Ma CS, Han Y, Zhao D. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome. Circulation. 2019 Apr 9;139(15):1776-1785. doi: 10.1161/CIRCULATIONAHA.118.037655.
Derived from this study: PubMed 42538061Wang C, Xu Z, Hao YC. Factors associated with length of stay among patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the CCC-ACS project. Open Heart. 2026 Jul 31;13(2):e004238. doi: 10.1136/openhrt-2026-004238.
Derived from this study: PubMed 41972267Zhang M, Zhao Z, Liu Y, Ma H, Wang K, Liu T, Yang W, Zhao Y, Luo W, Zhao X, Zheng K, Yin C, Zhang X, Gao H, Zhou C, Zhao D. Transradial Access vs. Transfemoral Access for Primary PCI in ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: Findings from a National, Multicenter Registry and Meta-Analysis. Korean Circ J. 2026 Aug;56(8):694-709. doi: 10.4070/kcj.2025.0251. Epub 2026 Mar 11.
Derived from this study: PubMed 41656976Liu Y, Liu X, Sun D, Gu R, Li M, Wang X. Aspirin Combined With Ticagrelor or Clopidogrel in STEMI Patients With Diabetes Mellitus and Poor Glycemic Control Undergoing Primary PCI: A Multicenter Retrospective Cohort Study. Catheter Cardiovasc Interv. 2026 Apr;107(5):1562-1572. doi: 10.1002/ccd.70503. Epub 2026 Feb 8.
Derived from this study: PubMed 41469572Fan C, Yan H, Lei K, Li D, Dong S, Zhang Y, Callister CP, Cheng Y, Li Z, Li Z, Qian H, Huang J. In-hospital outcomes of percutaneous coronary intervention in acute coronary syndrome patients with heart failure: a real-world observational study from the CCC-ACS registry. BMC Cardiovasc Disord. 2025 Dec 30;26(1):62. doi: 10.1186/s12872-025-05389-x.
Derived from this study: PubMed 41143351Zhou Z, Xie H, Fan F, Yang F, Jiang J, Zheng B, Zhang Y, Hao Y, Liu J, Gong Y, Zhao D, Smith SC, Huo Y. Comparison of in-hospital net clinical outcomes of ticagrelor and clopidogrel in acute coronary syndrome patients stratified by CRUSADE score: findings from the CCC-ACS registry. Platelets. 2025 Dec;36(1):2570743. doi: 10.1080/09537104.2025.2570743. Epub 2025 Oct 27.

Related trials for Acute Coronary Syndrome

RecruitingPhase 4
CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome
ACS (Acute Coronary Syndrome), SGLT2 Inhibitors
Recruiting
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
Coronary Arterial Disease (CAD), Plaque
Not yet recruitingPhase 4
Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia
Acute Coronary Syndrome
Enrolling by invitation
Optical Coherence Tomography in Acute Vessel Evaluation
Ischemic Heart Disease, Ischemic Coronary Artery Disease
Not yet recruitingPhase 3
Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis
Giant Cell Arteritis (GCA), Acute Coronary Syndrome (ACS)

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Dong Zhao, Ph. D principal investigator

Beijing Institute of Heart, Lung and Blood Vessel Diseases

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Coronary Syndrome, run by Beijing Institute of Heart, Lung and Blood Vessel Diseases at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The overall composite of 11 performance measures for ACS care (time frame: Duration of hospital stay, an expected average of 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02306616, which also lists 39 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2021.